XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 120,215 $ 49 $ 414,956 $ (294,790)
Beginning Balance, shares at Dec. 31, 2023   49,131,363    
Issuance of common stock upon exercise of stock options, shares   132,958    
Issuance of common stock upon exercise of stock options 145   145  
Issuance of common stock upon vesting of restricted stock units   $ 1 (1)  
Issuance of common stock upon vesting of restricted stock units, shares   300,879    
Warrant issuance 609   609  
Stock-based compensation expense 4,506   4,506  
Net Income (Loss) (16,266)     (16,266)
Ending Balance at Mar. 31, 2024 109,209 $ 50 420,215 (311,056)
Ending Balance, shares at Mar. 31, 2024   49,565,200    
Beginning Balance at Dec. 31, 2024 87,523 $ 51 433,769 (346,297)
Beginning Balance, shares at Dec. 31, 2024   50,937,999    
Issuance of common stock upon exercise of stock options, shares   35,168    
Issuance of common stock upon exercise of stock options 63   63  
Issuance of common stock upon vesting of restricted stock units, shares   403,584    
Withholding taxes on net share settlement of restricted stock units (47)   (47)  
Stock-based compensation expense 4,243   4,243  
Net Income (Loss) (14,154)     (14,154)
Ending Balance at Mar. 31, 2025 $ 77,628 $ 51 $ 438,028 $ (360,451)
Ending Balance, shares at Mar. 31, 2025   51,376,751